colorectal cancer
A new study published in Science claims that some gut microbes produce a metabolite that boosts the effect of a class of cancer drugs.
A metabolite produced by the gut microbiota increases the risk of colon cancer in mice prone to the disease, a new study has found.
Researchers have found that the gut microbiota and the death of intestinal cells caused by chemotherapy can enhance the immune response of people with colon cancer.
Researchers developed a new tool to modulate the gut microbiota for neutralizing the tumor-promoting microenvironment.
Bacteria are critical in determining the outcome of surgical procedure. We talked about this with James Kinross from the Imperial College London.
Researchers from the University of Trento have found that specific changes in gut microbiota composition are associated with colorectal cancer.
Scientists may have just figured out how colibactin, a DNA-damaging molecule produced by certain strains of E. coli, contributes to colorectal cancer.
